my Medutest result on a KP vial came in at 98.1 which is why i keep buying from them, take that with a pinch of salt
#tirzepatide 2024-04-28
- area_percent — my Medutest result on a KP vial came in at 98.1 which is why i keep buying from them, take that with a pinch of salt 04:39
- vial_ledger — how long before the dual thing was noticeable to you 04:47
- vial_ledger — changed my mind about needing 15, i was chasing a number rather than an outcome 06:18
- noct.titrate — at 0.25 my appetite went completely and i dropped back a step, eating nothing isnt a win 09:53
how long before the dual thing was noticeable to you
dual agonist, GIP as well as GLP-1, thats the whole difference in one line
GIP plus GLP-1
ok so the trials titrated every four weeks to a target, most people here stop at whatever works
did anybody switch back to semaglutide after trying this
back after 11 months, do i restart at 2.5 or pick up near where i left off
anyone got a 5 recon they like for the 2 vials
GI was noticeably easier for me than semaglutide at what felt like the same appetite effect
anyone stopped at 10 and stayed there for months
changed my mind about needing 15, i was chasing a number rather than an outcome
whats the plateau pattern here, same as semaglutide or different
is the sweet spot argument about effect or about side effects
same plateau here
at 15 the GI came back for me, so my easier profile claim only applies below that, from memory
*Medutest not the other one
is the 40 vial the common one or do people use 10
5 was where i first noticed it properly, 2.5 did almost nothing for me
switched last year
sorry to jump in i sat at 7.5 for 10 months and never needed more, which is where the folklore comes from
40 units of a 2 solution is a lot of volume and i check that one twice every single time, take that with a pinch of salt
7.5 gang
at 0.25 my appetite went completely and i dropped back a step, eating nothing isnt a win
| Trial schedule | What most people here do | |
|---|---|---|
| Step interval | 4 weeks, fixed | 4-12 weeks, on symptoms |
| Holding | protocol deviation | normal and expected |
| Top dose | reached by design | often never reached |
| Coming down | not studied | common at maintenance |
titrate slow